Ellen L. White

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.

Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.

Journal: Open forum infectious diseases

Published: January 26, 2026

Predictors of Treatment Failure in Children With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial.

Predictors of Treatment Failure in Children With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 16, 2025

Predictors of treatment failure in children living with HIV starting first-line antiretroviral therapy in the ODYSSEY trial.

Predictors of treatment failure in children living with HIV starting first-line antiretroviral therapy in the ODYSSEY trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 16, 2025

Weight gain, body composition, and metabolic parameters of dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: an ancillary analysis of the ODYSSEY trial.

Weight gain, body composition, and metabolic parameters of dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: an ancillary analysis of the ODYSSEY trial.

Journal: The Lancet. Child & adolescent health

Published: August 28, 2025

Evaluating the performance of automated detection systems for long-term monitoring of delphinids in diverse marine soundscapes.

Evaluating the performance of automated detection systems for long-term monitoring of delphinids in diverse marine soundscapes.

Journal: PloS one

Published: October 14, 2024

Sounds of the deep: How input representation, model choice, and dataset size influence underwater sound classification performance.

Sounds of the deep: How input representation, model choice, and dataset size influence underwater sound classification performance.

Journal: The Journal of the Acoustical Society of America

Published: September 20, 2024

Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.

Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.

Journal: The lancet. HIV

Published: November 07, 2023

Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.

Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.

Journal: The Lancet. Child & adolescent health

Published: March 06, 2023

Electronic health records to capture primary outcome measures: two case studies in HIV prevention research.

Electronic health records to capture primary outcome measures: two case studies in HIV prevention research.

Journal: Trials

Published: November 17, 2022

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial.

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial.

Journal: The lancet. HIV

Published: March 28, 2022

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.

Journal: The New England journal of medicine

Published: December 29, 2021

Prevalence and correlates of depressive symptoms among gay, bisexual and other men who have sex with men in the PROUD randomised clinical trial of HIV pre-exposure prophylaxis.

Prevalence and correlates of depressive symptoms among gay, bisexual and other men who have sex with men in the PROUD randomised clinical trial of HIV pre-exposure prophylaxis.

Journal: BMJ open

Published: December 13, 2019

Showing 1-12 of 25

Last Updated: 09/26/2026